Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer

被引:20
作者
Jayakumar, Asha [1 ]
Bothwell, Alfred L. M. [1 ]
机构
[1] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA
关键词
CD4(+) T-CELLS; INTESTINAL TUMORIGENESIS; TH17; CELLS; TGF-BETA; DIFFERENTIATION; ACCUMULATION; GENERATION; MDSCS; MICE; PROGRESSION;
D O I
10.4049/jimmunol.1900500
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) are immature suppressive cells found in tumors and immunological niches. In this article, we highlight the ability of MDSCs to promote IL-17-producing T cells (Th17) and regulatory T cells in addition to suppressing cytotoxic T cells in different tumor models. These interactions between MDSCs and T cells support tumor growth because IL-17 is tumorigenic in many cancer types and regulatory T cells suppress antitumor T cells. Besides T cells, MDSCs promote regulatory B cells and suppress overall B cell function; however, tumor-evoked regulatory B cells also regulate MDSC function, suggesting cross-regulation between MDSCs and B cells. These multiple functions shed light on how MDSCs dysregulate several arms of host immune response. Moreover, MDSCs promote tumor cell survival and angiogenesis to support tumors. Therefore, the multifunctional feature of MDSCs make them attractive immunotherapeutic targets.
引用
收藏
页码:1095 / 1103
页数:9
相关论文
共 50 条
  • [21] The role of myeloid-derived suppressor cells in gastrointestinal cancer
    Cui, Cheng
    Lan, Penglin
    Fu, Li
    [J]. CANCER COMMUNICATIONS, 2021, 41 (06) : 442 - 471
  • [22] Suppression of T cells by myeloid-derived suppressor cells in cancer
    Chen, Jieying
    Ye, Yingnan
    Liu, Pengpeng
    Yu, Wenwen
    Wei, Feng
    Li, Hui
    Yu, Jinpu
    [J]. HUMAN IMMUNOLOGY, 2017, 78 (02) : 113 - 119
  • [23] Myeloid-derived suppressor cells in immunity and autoimmunity
    Yang, Hui
    Bi, Yujing
    Han, Fei
    Lu, Yun
    Wang, Jian
    Zhang, Zhengguo
    Liu, Guangwei
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (08) : 911 - 919
  • [24] Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
    Diaz-Montero, C. Marcelo
    Finke, Jim
    Montero, Alberto J.
    [J]. SEMINARS IN ONCOLOGY, 2014, 41 (02) : 174 - 184
  • [25] Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
    Donkor, Moses K.
    Lahue, Elaine
    Hoke, Traci A.
    Shafer, Laura R.
    Coskun, Ugur
    Solheim, Joyce C.
    Gulen, Dumrul
    Bishay, John
    Talmadge, James E.
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (7-8) : 937 - 948
  • [26] Myeloid-Derived Suppressor Cells in Sepsis
    Schrijver, Irene T.
    Theroude, Charlotte
    Roger, Thierry
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [27] Neutrophils as myeloid-derived suppressor cells
    Aarts, Cathelijn E. M.
    Kuijpers, Taco W.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48
  • [28] The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
    Dong, Peng
    Yan, Yu
    Fan, Yujun
    Wang, Hui
    Wu, Danzhu
    Yang, Liyuan
    Zhang, Junpeng
    Yin, Xiaoyang
    Lv, Yajuan
    Zhang, Jiandong
    Hou, Yuzhu
    Liu, Fengjun
    Yu, Xinshuang
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [29] Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
    Santibanez, Juan F.
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2025, 30 (03):
  • [30] Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
    Klein, Clement
    Mebroukine, Samy
    Madery, Mathilde
    Moisand, Alexandra
    Boyer, Thomas
    Larmonier, Nicolas
    Robert, Gregoire
    Domblides, Charlotte
    [J]. CELLS, 2024, 13 (21)